| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | - | - | |
| Other | 425.0K | - | - | |
| Other | 282.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 6,576 | $6.74 | $44,322.24 | -2.0% | |
| Mar 25, 2025 | Carrie Liao | Chief Accounting Officer | Sell10b5-1 | 2,347 | $6.74 | $15,818.78 | -1.6% | |
| Mar 25, 2025 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 21,208 | $6.74 | $142,941.92 | -2.4% | |
| Dec 26, 2024 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 19,106 | $7.43 | $141,957.58 | -3.5% | |
| Dec 26, 2024 | Carrie Liao | Chief Accounting Officer | Sell10b5-1 | 2,273 | $7.43 | $16,888.39 | -2.3% | |
| Dec 26, 2024 | Dan Karlin | Chief Medical Officer | Sell10b5-1 | 6,643 | $7.43 | $49,357.49 | -1.9% | |
| Dec 26, 2024 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 4,519 | $7.43 | $33,576.17 | -2.5% | |
| Dec 5, 2024 | David W Gryska | Director | Buy | 2,500 | $7.17 | $17,925.00 | +14.4% | |
| Sep 25, 2024 | Carrie Liao | Chief Accounting Officer | Sell10b5-1 | 2,352 | $5.98 | $14,064.96 | -2.3% | |
| Sep 25, 2024 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 19,771 | $5.98 | $118,230.58 | -3.5% |